# A Clinical Study Evaluating the Safety and Efficacy of Anti-HER2-CAR-T Cells Injection in Patients With Solid Tumors

> **NCT06101082** · PHASE1 · RECRUITING · sponsor: **China Medical University, China** · enrollment: 9 (estimated)

## Conditions studied

- Solid Tumor

## Interventions

- **BIOLOGICAL:** Intravenous infusion anti-HER2-CAR-T cell

## Key facts

- **NCT ID:** NCT06101082
- **Lead sponsor:** China Medical University, China
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-16
- **Primary completion:** 2026-10-19
- **Final completion:** 2026-10-19
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2024-03-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06101082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06101082, "A Clinical Study Evaluating the Safety and Efficacy of Anti-HER2-CAR-T Cells Injection in Patients With Solid Tumors". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06101082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*